Cardiovascular Health Assessment of Preterm- and TERm-born Children
NCT ID: NCT05698836
Last Updated: 2023-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
200 participants
OBSERVATIONAL
2019-03-21
2036-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Young Adult Cardiovascular Health sTudy
NCT02103231
What is the Impact of Early Life Exposures on the Cardiovascular System in Young Adulthood?
NCT01487824
Preterm Birth and Long Term Consequences on Myocardial Functions and Structure
NCT03589365
Effects of Transitional Circulation in ELBW Infants
NCT02016599
Prediction of Adverse Outcome Using Fetal MRI in Pregnancies at Risk of Preterm Birth
NCT05164432
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participant is male or female, aged 3-9 years at enrolment.
* Participant previously took part in the EPOCH study, or the participant's friend or sibling took part.
Exclusion Criteria
For exclusion of MRI component only:
* Contraindication to MRI
* Unsuitable for MRI based on the responses to the MRI screening form
3 Years
9 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oxford
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adam Lewandowski, DPhil
Role: PRINCIPAL_INVESTIGATOR
University of Oxford
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Oxford
Oxford, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18/WM/0131
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.